地尔硫卓干预冠心病患者PCI术后再狭窄的疗效

Efficacy of diltiazem intervention on restenosis after PCI in patients with coronary heart disease

目的:探究地尔硫卓干预冠心病患者PCI术后再狭窄的效果。方法:将2015年1月~2017年1月作为本次研究时间段,选择80例冠心病PCI术后再狭窄患者展开本次研究;在征得患者或其家属同意的基础上对40例实施常规治疗(对照组),对另外40例在常规治疗基础上应用地尔硫卓(观察组);治疗后比较两组效果。结果:两组患者在无差异的基础上分组治疗后,观察组再狭窄例数1(2.5%)显著少于对照组的6(15.0%),且两组比较差异具有统计学意义(P<0.05)。结论:地尔硫卓干预冠心病患者PCI术后再狭窄疗效良好,相比常规方法可显著降低再狭窄发生率,因此具有应用价值。

Objective：To investigate the effect of diltiazem on restenosis after PCI in patients with coronary heart disease.Methods：From January 2015 to January 2017 as the study period,80 patients with coronary artery disease who underwent PCI were enrolled in this study. Forty patients underwent general anesthesia with consent of patients or their families（Control group）. Diltiazem（observation group）was given to 40 patients on the basis of routine treatment. After treatment,the effects of the two groups were compared.Results：Two groups of patients on the basis of no difference in the treatment group,the observation group restenosis number 1（2.5%） was significantly less than the control group 6（15.0%）,and the two groups was statistically significant（P〈0.05）.Conclusions：Diltiazem intervention in patients with coronary artery disease after PCI restenosis good effect, compared with conventional methods can significantly reduce the incidence of restenosis,it has application value.